27
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Complementary and Alternative Medicine: What Is Its Role?

Pages 221-230 | Published online: 03 Jul 2009

REFERENCES

  • Harwood A. Ethnicity and medical care. Cambridge, Massachu- setts: Harvard University Press, 1981.
  • Harwood A. Rx—spiritist as needed: a study of a Puerto Rican community mental health resource. New York: Wiley, 1977.
  • Howell JD. The paradox of osteopathy [Letter]. N Engl J Med 1999;341:1465–8.
  • Cohen ML. Changing patterns of infectious disease. Nature 2000;406:762–7.
  • Eisenberg L. The social imperatives of medical research. Science 1977;198:1105–10.
  • Peabody FW. Doctor and patient: papers on the relationship of the physician to men and institutions. New York: Macmillan, 1930.
  • Mischoulon D, Rosenbaum JF. The use of natural remedies in psychiatry: a commentary. Harvard Rev Psychiatry 1999;6:279–83.
  • Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the United States, 1900–1997: results of a follow-up national study. JAMA 1998;280:1569–75.
  • Kessler RC, Soukup J, Davis RB, Foster DF, Wilkey SA, Van Rompay MI, et al. The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am J Psychiatry 2001;158:289–94.
  • Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D. St. John’s wort for depression: an overview and meta-analysis of randomised clinical trials. BMJ 1996;313:253–8.
  • Stevinson C, Ernst E. Hypericum for depression: an update of the clinical evidence. Eur Neuropsychopharmocol 1999;9:501–5.
  • Shelton RC, Keller MB, Gelenberg A, Dunner DL, Hirschfeld R, Thase ME, et al. Effectiveness of St. John’s wort in major de- pression: a randomized controlled trial. JAMA 2001;285:1978–86.
  • Hypericum Depression Trial Study Group. Effect of Hypericum perforatum (St. John’s wort) in major depressive disorder: a ran- domized controlled trial. JAMA 2002;287:1807–14.
  • Walsh BT, Seidman SN, Sysko R, Gould M. Placebo responses in studies of major depression: variable, substantial, and growing. JAMA 2002;287:1840–7.
  • Kupfer DJ, Frank E. Placebo in clinical trials for depression: complexity and necessity. JAMA 2002;287:1853–4.
  • Fugh-Berman A. Herb-drug interactions. Lancet 2000;355:134–8.
  • Vogel G. How the body’s “garbage disposal” may inactivate drugs. Science 2001;291:35–7.
  • Piscitelli SC, Burstein AH, Chaitt D, Alfaro RM, Falloon J. Indi- navir concentrations and St. John’s wort [Letter]. Lancet 2000;355:547–8.
  • Ernst E. Second thoughts about safety of St. John’s wort. Lancet 1999;354:2014–6.
  • Volz HP, Kieser M. Kava-kava extract WS 1490 versus placebo in anxiety disorders: a randomized placebo-controlled 25-week outpatient trial. Pharmacopsychiatry 1997;30:1–5.
  • Woelk H, Kapoula O, Lehrl S, Schröter K, Weinholz P. Behand- lung von Angst-Patienten: Doppelblindstudie: Kava-Spezial- extrakt WS 1490 versus Benzodiazepine. Z Allg Med 1993; 69:271–7.
  • Craft LL, Landers DM. The effect of exercise on clinical depres- sion and depression resulting from mental illness: a meta- analysis. J Sport Exercise Psychol 1998;20:339–57.
  • Moore KA, Blumenthal JA. Exercise training as an alternative treatment for depression among older adults. Altern Ther Health Med 1998;4:48–56.
  • Needham J. Science in traditional China: a comparative per- spective. Cambridge, Massachusetts: Harvard University Press, 1981.
  • Eisenberg L. What makes persons “patients” and patients “well”? Am J Med 1980;69:277–86.
  • Hart JT, Dieppe P. Caring effects. Lancet 1996;347:1606–8.
  • Anonymous. Influence of adherence to treatment and response of cholesterol on mortality in the Coronary Drug Project. N Engl J Med 1980;303:1038–41.
  • Anonymous. When primum non nocere fails. Lancet 2000; 355:2007.
  • Gruenberg EM. The social breakdown syndrome: some origins. Am J Psychiatry 1967;123:1481–9.
  • Goffman E. Asylums; essays on the social situation of mental pa- tients and other inmates. Garden City, New York: Doubleday, 1961.
  • Shepherd M, Goodman N, Watt BC. The application of hospital statistics in the evaluation of pharmacotherapy in a psychiatric population. Compr Psychiatry 1961;2:11–9.
  • Ødegard Ø. Pattern of discharge from Norwegian psychiatric hospitals before and after the introduction of the psychotropic drugs. Am J Psychiatry 1964;120:772–8.
  • Pressman JD. Last resort: psychosurgery and the limits of med- icine. New York: Cambridge University Press, 1998.
  • Ahmad K. Namibian government to prosecute healers. Lancet 2001;357:371.
  • Eddleston M, Rajapakse S, Rajakanthan, Jayalath S, Sjöström L, Santharaj W, et al. Anti-digoxin Fab fragments in cardiotox- icity induced by ingestion of yellow oleander. Lancet 2000; 355:967–72.
  • Nortier JL, Martinez MCM, Schmeiser HH, Arlt VM, Bieler CA, Petein M, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 2000; 342:1686–92.
  • Kessler DA. Cancer and herbs. [Letter] N Engl J Med 2000;342:1742–3.
  • Kershaw S. City shuts unlicensed clinic catering to Chinese im- migrants. NY Times, 17 Aug 2000:A27.
  • Steinhauer J. For some New York immigrants, a vast alterna- tive health care system, underground. NY Times, 20 Aug 2000: A24.
  • Middleton WS. The yellow fever epidemic of 1793 in Philadel- phia. Ann Med History 1928;10:434–50.
  • Young A. Some implications of medical beliefs and practices for social anthropology. Am Anthropol 1976;78:5–24.
  • Turner VW. Revelation and divination in Ndembu ritual. Ithaca, New York: Cornell University Press, 1975.
  • Lindenbaum S. Kuru sorcery: disease and danger in the New Guinea highlands. Palo Alto, California: Mayfield, 1979.
  • Horton R. African traditional thought and western science. Africa 1967;37:50–71, 155–87.
  • Anonymous. Which anticonvulsant for women with eclampsia: evidence from the Collaborative Eclampsia Trial. Lancet 1995; 345:1455–63.
  • Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magne- sium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995;333:201–5.
  • Roberts JM. Magnesium for preeclampsia and eclampsia [Let- ter]. N Engl J Med 1995;333:250–1.
  • Thornley B, Adams C. Content and quality of 2000 controlled tri- als in schizophrenia over 50 years. BMJ 1998;317:1181–4.
  • Eisenberg L. Treating depression and anxiety in primary care: closing the gap between knowledge and practice. N Engl J Med 1992;326:1080–4.
  • Wetzel MS, Eisenberg DM, Kaptchuk TJ. Courses involving complementary and alternative medicine at US medical schools. JAMA 1998;280:784–7.
  • Stokstad E. Stephen Straus’s impossible job. Science 2000; 288:1568–70.
  • La Ferla R. Hospitals are discovering their inner spa. NY Times, 13 Aug 2000:D1
  • Eisenberg L. Whatever happened to the faculty on the way to the agora? Arch Int Med 1999;159:2251–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.